E. Bromidge
Papers
1
Total Citations
9
H-Index
1
About
E. Bromidge has made significant contributions to the diagnosis and understanding of von Willebrand Disease (VWD), particularly the rare Type 2N variant. Their key research focuses on the critical interaction between von Willebrand factor (VWF) and factor VIII (FVIII), a binding process essential for normal blood coagulation. Bromidge's most notable work, the 2002 study "Evaluation of an automated screening assay for von Willebrand Disease Type 2N," introduced a practical, automated method to assess FVIII binding activity of VWF. This assay streamlined the diagnostic work-up for families with apparent mild haemophilia A, enabling clinicians to distinguish between true haemophilia and VWD Type 2N—a distinction crucial for appropriate patient management. With 9 citations, this work has served as a foundational reference for subsequent research and clinical protocols in haemostasis. Bromidge’s contributions have directly improved diagnostic accuracy for bleeding disorders, helping to ensure that patients receive correct genetic counseling and treatment. Their research remains a valuable resource for haematologists and clinical scientists working to unravel the complexities of VWF-related pathologies.
Research Focus
Key Achievements
Top Papers
- 1